Expertise in
15
conditions

Dr. Mary B. Scholand

Pulmonary Medicine
1280 E Stringham Ave, 
Salt Lake City, UT 
Accepting New Patients
Offers Telehealth
Expertise in
15
conditions
1280 E Stringham Ave, 
Salt Lake City, UT 

Overview

Mary Scholand is a Pulmonary Medicine provider practicing medicine in Salt Lake City, Utah.

Dr. Scholand is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Interstitial Lung Disease, Acute Interstitial Pneumonia, Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis, and Lung Transplant.

Dr. Scholand is board certified in American Board Of Internal Medicine. She is actively involved in clinical research, co-authoring 76 peer reviewed articles and participating in 6 clinical trials. Dr. Scholand is currently accepting new patients.

Specialties

Pulmonary Medicine

Licenses

Internal Medicine in UT

Board Certifications

American Board Of Internal Medicine

Hospital Affiliations

Castleview Hospital
Intermountain Health Mckay-Dee Hospital
University Of Utah Hospital And Clinics
Intermountain Health Layton Hospital
Memorial Hospital Sweetwater County

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
BridgeSpan
  • EPO
  • HMO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Deseret Mutual Benefit Administrators
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HMSA
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Mountain Health
  • OTHER COMMERCIAL
  • POS
  • PPO
PacificSource
  • PPO
Regence
  • EPO
  • PPO
SelectHealth
  • HMO
  • POS
Silversummit Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
Steward Health Care
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
University of Utah Health
  • EPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 20 Less Insurance Carriers -

Locations

Pulmonary Division - Sugarhouse
1280 E Stringham Ave, Salt Lake City, UT 84106

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-1)
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-1)
Enrollment Status: Completed
Publish Date: May 05, 2026
Intervention Type: Device, Drug
Study Drug: Treprostinil
Study Phase: Phase 3
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Terminated
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 3
Scleroderma Lung Study III (SLS III): Combining the Anti-fibrotic Effects of Pirfenidone (PFD) With Mycophenolate (MMF) for Treating Scleroderma-related Interstitial Lung Disease
Scleroderma Lung Study III (SLS III): Combining the Anti-fibrotic Effects of Pirfenidone (PFD) With Mycophenolate (MMF) for Treating Scleroderma-related Interstitial Lung Disease
Enrollment Status: Completed
Publish Date: December 15, 2023
Intervention Type: Drug
Study Drugs: Pirfenidone, Mycophenolate Mofetil
Study Phase: Phase 2
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Biological Activity, and PK of ND-L02-s0201 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Biological Activity, and PK of ND-L02-s0201 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Completed
Publish Date: December 11, 2023
Intervention Type: Drug, Other
Study Drug: ND-L02-s0201
Study Phase: Phase 2
Pulmonary Fibrosis Foundation Patient Registry
Pulmonary Fibrosis Foundation Patient Registry
Enrollment Status: Completed
Publish Date: July 07, 2023
A Randomized, Phase 2, Open-Label, Multicenter Study to Evaluate the Safety, Tolerability, and Activity of Belumosudil in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
A Randomized, Phase 2, Open-Label, Multicenter Study to Evaluate the Safety, Tolerability, and Activity of Belumosudil in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Completed
Publish Date: September 08, 2022
Intervention Type: Other, Drug
Study Drug: KD025
Study Phase: Phase 2
View 5 Less Clinical Trials

76 Total Publications

A Proposed Clinical Diagnostic Framework for Short Telomere Syndrome.
A Proposed Clinical Diagnostic Framework for Short Telomere Syndrome.
Journal: Clinical genetics
Published: May 02, 2026
Similar Doctors
Expertise in
6
conditions
Dr. Nathan C. Dean
Pulmonary Medicine
Expertise in
6
conditions
Dr. Nathan C. Dean
Pulmonary Medicine
Referral may be required
Before you request

Schmidt Chest Clinic

5171 S Cottonwood St, 
Salt Lake City, UT 
 (4.7 miles away)
801-507-4800
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Philosophy of care statement/quote: I enjoygetting to know my patients as individuals andworking as partners to improve their healthI am originally from: Palo Alto, CaliforniaMy clinical interests are: Recurrent pneumonia,bronchiectasis, non-tuberculous mycobacteriaand other chronic lung infections. When not working, I enjoy: Family especially mygrandchildren, skiing including being a medicaladvisor to the Alta Ski Patrol, road cycling, hiking,backpacking, and travel to Mexico and Spain. Dr. Dean is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Pneumonia, Bronchiectasis, Hospital-Acquired Pneumonia, and H1N1 Influenza. Dr. Dean is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine , and American Board Of Internal Medicine. Dr. Dean is currently accepting new patients.

Expertise in
37
conditions
Dr. Mustufa T. Saifee
Pulmonary Medicine | Sleep Medicine
Expertise in
37
conditions
Dr. Mustufa T. Saifee
Pulmonary Medicine | Sleep Medicine
Referral may be required
Before you request

Intermountain Healthcare

5373 South Green Street, TeleHealth, Suite 400, 
Salt Lake City, UT 
 (5.5 miles away)
801-442-2000
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients
Offers Telehealth

All pulmonary diseases. All Sleep disorder. Intensive care medicine. Dr. Saifee is highly rated in 37 conditions, according to our data. His clinical expertise encompasses Central Sleep Apnea, Obstructive Sleep Apnea, Lung Metastases, Chronic Cough, and Gastrostomy. Dr. Saifee is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Saifee is currently accepting new patients.

Expertise in
6
conditions
Dr. Richard E. Kanner
Pulmonary Medicine
Expertise in
6
conditions
Dr. Richard E. Kanner
Pulmonary Medicine
Referral may be required

Pulmonology

50 N Medical Dr # B, 
Salt Lake City, UT 
 (3.3 miles away)
801-581-7806
Languages Spoken:
English
See accepted insurances

Richard Kanner is a Pulmonary Medicine provider practicing medicine in Salt Lake City, Utah. Dr. Kanner is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Cerebral Hypoxia, and Bronchitis.

Frequently Asked Questions about Dr. Mary B. Scholand

How do I make an appointment with Dr. Mary B. Scholand?

You can book an appointment with Dr. Mary B. Scholand by calling their office at 801-581-7806. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Mary B. Scholand a top-rated expert for Interstitial Lung Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mary B. Scholand is classified as an Elite expert for Interstitial Lung Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Mary B. Scholand specialize in?

While Dr. Mary B. Scholand is a Pulmonary Medicine, they have specific expertise in Interstitial Lung Disease, Acute Interstitial Pneumonia, and Pulmonary Fibrosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pulmonary Medicine.

Does Dr. Mary B. Scholand participate in research or clinical trials?

Yes. Dr. Mary B. Scholand has published 76 articles and abstracts on conditions like Interstitial Lung Disease. You can view a list of Dr. Mary B. Scholand's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Mary B. Scholand accept my insurance?

Dr. Mary B. Scholand accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 801-581-7806 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Scholand's expertise for a condition
ConditionClose
View All 7 Elite Conditions
View All 12 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile